Paving the Way for Next Generation Experimentation with Self Driving Labs - A Preview of Our Keynote Presentation at the 2021 Smart Labs, Automation & Technology Virtual Summit
Strateos is delighted to have our CEO Mark Fischer-Colbrie deliver a keynote presentation at the upcoming 2021 Smart Labs, Automation, & Technology Summit on May 19th.
Strateos is delighted to have our CEO Mark Fischer-Colbrie deliver a keynote presentation at the upcoming 2021 Smart Labs, Automation, & Technology Summit on May 19th. This Virtual Summit will focus on identifying, selecting, and implementing appropriate automation technology to accelerate early discovery and R&D to increase efficiency, productivity, and quality of laboratory workflows.
Mark brings more than 30 years of experience building and growing automation capabilities for laboratory tools, diagnostics, and medical devices to serve the needs of the biopharmaceutical industry. At Strateos, he continues to build on this vision through the creation of new knowledge driven by data, computation, automation, and high-throughput robotics.
Strateos aims to help scientists produce cleaner and more reproducible data at a faster pace, with the fundamental goal of accelerating discovery across all areas of the life sciences by reimagining labs as data rich centers.
Increased Demand for Reliable, Actionable Data Coupled with R&D Investment Drives the Need for Laboratory Automation
Laboratory workflows in the biotechnology and pharmaceutical industry have become increasingly more complex, which has driven a need for digital solutions and laboratory automation tools to generate actionable data that facilitate near real-time decision making. The World Health Organization predicts growth in the pharmaceutical market will increase at a rate of 5% annually, exceeding $1.8 trillion in expenditures by 2024. Much of this investment will focus on R&D lab automation solutions and technology integration for clinical diagnostic and drug discovery workflows.
The trend towards automation, connectivity, and improved data acquisition to accelerate R&D will require collaboration between biopharma and research organizations along with technology providers to realize the potential of end-to-end laboratory automation.
AMG World’s 2021 Smart Labs, Automation & Technology Virtual Summit
AMG World has garnered an extensive network of industry leaders and innovators, including Bristol Myers Squibb, GlaxoSmithKline, Roche, and Eli Lilly, to explore the topic of laboratory automation during this year’s Smart Labs, Automation, & Technology Summit through keynote presentations, round table discussions, and other virtual content. This event provides an opportunity to discover emerging technology platforms for lab automation and effective data governance, discuss key drivers to digitize existing workflows, as well as engage in dialogue with solutions providers and biopharma to navigate the path to successful implementation of lab management software and automated tools to accelerate early drug discovery and R&D.
Mark will be delivering a keynote presentation entitled Paving the Way for Next Generation Experimentation with Self Driving Labs where he will discuss how labs can be reimagined and redefined as data-rich centers to accelerate the path to scientific discovery. A real-world case study will be presented to highlight how Strateos’ automated cloud labs enable scientists globally to achieve newer and faster scientific discoveries by focusing on experimental design and developing new hypotheses while liberating them from managing the complexities of automation. Additionally, Strateos will be sponsoring and moderating the first roundtable discussion of the summit, “Developing the Roadmap towards Optimized, Connected Smart Labs of the Future”. Join us during this interactive conversation on May 19th!
For more information on general conference information and to register for the free event, please click on this link: https://www.amg-world.co.uk/smart-lab-automation-and-technology/